Issue Date | Title | Author(s) |
2019-01-10 | Assessing the exertion required to induce breathlessness in a population with advanced cancer: Matching measures to the level of physical function | White, KM; Agar, MR; Currow, DC |
2021-01-28 | A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer | Currow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR |
2023 | Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study. | Lee, W; Sheehan, C; Chye, R; Chang, S; Bayes, A; Loo, C; Draper, B; Agar, MR; Currow, DC; Akena, D |
2023-10 | Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade glioma. | Campbell, R; Faris, M; Shaw, J; Halkett, GKB; Legge, D; Koh, E-S; Nowak, AK; Agar, MR; Ownsworth, T; Pike, KE; Chan, RJ; Dhillon, HM |
2023 | Mobile-Based Application Interventions to Enhance Cancer Control and Care in Low- and Middle-Income Countries: A Systematic Review. | Donkor, A; Ayitey, JA; Adotey, PN; Ofori, EO; Kitson-Mills, D; Vanderpuye, V; Opoku, SY; Luckett, T; Agar, MR; Engel-Hills, P |
2023-10-12 | Participant Safety in Multisite, Randomized, Double-Blind, Placebo-Controlled Clinical Trials in Hospice/Palliative Care: Data from the Contracted Studies of the Australian National Palliative Care Clinical Studies Collaborative. | Currow, DC; Fazekas, B; Brown, L; Kochovska, S; Clark, K; Agar, MR |
2024-04-08 | "You're the only thing he comes out [of his room] for": A qualitative study of engagement between Laughter Care Specialists and families of people with dementia in long-term care. | DiGiacomo, M; Roberts, S-J; Luckett, T; Symons, D; Ellis, G; Kochovska, S; Warner, T; Currow, DC; Parker, D; Payne, K; Agar, MR |
2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
2024-04-29 | Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations. | Hart, NH; Nekhlyudov, L; Smith, TJ; Yee, J; Fitch, MI; Crawford, GB; Koczwara, B; Ashbury, FD; Lustberg, MB; Mollica, M; Smith, AL; Jefford, M; Chino, F; Zon, R; Agar, MR; Chan, RJ |
2024-06-03 | Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study. | Landers, A; Brown, H; Al Ruheili, J; Russell, K; McKenzie, C; Agar, MR; Yenson, VM; Clarke, K; Windsor, J |